Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153], (S1476558616302640), (10.1016/j.neo.2016.12.005))

Ki Cheong Park, Seok Mo Kim, Jeong Yong Jeon, Bup Woo Kim, Hyeung Kyoo Kim, Ho Jin Chang, Yong Sang Lee, Soo Young Kim, Seung Hoon Choi, Cheong Soo Park, Hang-Seok Chang

Research output: Contribution to journalComment/debate

Abstract

The authors discovered an error in Figure 3A. The band for Apaf-1 in Figure 3A was inserted in reversed manner and is presented correctly below.

Original languageEnglish
Number of pages1
JournalNeoplasia (United States)
Volume19
Issue number8
DOIs
Publication statusPublished - 2017 Aug 1

Fingerprint

Neoplastic Stem Cells
Neoplasms
sorafenib
Anaplastic Thyroid Carcinoma
corrigendum

All Science Journal Classification (ASJC) codes

  • Cancer Research

Cite this

Park, Ki Cheong ; Kim, Seok Mo ; Jeon, Jeong Yong ; Kim, Bup Woo ; Kim, Hyeung Kyoo ; Chang, Ho Jin ; Lee, Yong Sang ; Kim, Soo Young ; Choi, Seung Hoon ; Park, Cheong Soo ; Chang, Hang-Seok. / Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153], (S1476558616302640), (10.1016/j.neo.2016.12.005)). In: Neoplasia (United States). 2017 ; Vol. 19, No. 8.
@article{773eb72b8775471cba442d4f7c5264ff,
title = "Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153], (S1476558616302640), (10.1016/j.neo.2016.12.005))",
abstract = "The authors discovered an error in Figure 3A. The band for Apaf-1 in Figure 3A was inserted in reversed manner and is presented correctly below.",
author = "Park, {Ki Cheong} and Kim, {Seok Mo} and Jeon, {Jeong Yong} and Kim, {Bup Woo} and Kim, {Hyeung Kyoo} and Chang, {Ho Jin} and Lee, {Yong Sang} and Kim, {Soo Young} and Choi, {Seung Hoon} and Park, {Cheong Soo} and Hang-Seok Chang",
year = "2017",
month = "8",
day = "1",
doi = "10.1016/j.neo.2017.05.006",
language = "English",
volume = "19",
journal = "Neoplasia",
issn = "1522-8002",
publisher = "Elsevier Inc.",
number = "8",

}

Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153], (S1476558616302640), (10.1016/j.neo.2016.12.005)). / Park, Ki Cheong; Kim, Seok Mo; Jeon, Jeong Yong; Kim, Bup Woo; Kim, Hyeung Kyoo; Chang, Ho Jin; Lee, Yong Sang; Kim, Soo Young; Choi, Seung Hoon; Park, Cheong Soo; Chang, Hang-Seok.

In: Neoplasia (United States), Vol. 19, No. 8, 01.08.2017.

Research output: Contribution to journalComment/debate

TY - JOUR

T1 - Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153], (S1476558616302640), (10.1016/j.neo.2016.12.005))

AU - Park, Ki Cheong

AU - Kim, Seok Mo

AU - Jeon, Jeong Yong

AU - Kim, Bup Woo

AU - Kim, Hyeung Kyoo

AU - Chang, Ho Jin

AU - Lee, Yong Sang

AU - Kim, Soo Young

AU - Choi, Seung Hoon

AU - Park, Cheong Soo

AU - Chang, Hang-Seok

PY - 2017/8/1

Y1 - 2017/8/1

N2 - The authors discovered an error in Figure 3A. The band for Apaf-1 in Figure 3A was inserted in reversed manner and is presented correctly below.

AB - The authors discovered an error in Figure 3A. The band for Apaf-1 in Figure 3A was inserted in reversed manner and is presented correctly below.

UR - http://www.scopus.com/inward/record.url?scp=85022021550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85022021550&partnerID=8YFLogxK

U2 - 10.1016/j.neo.2017.05.006

DO - 10.1016/j.neo.2017.05.006

M3 - Comment/debate

C2 - 28739012

AN - SCOPUS:85022021550

VL - 19

JO - Neoplasia

JF - Neoplasia

SN - 1522-8002

IS - 8

ER -